Rocheusa ( Rocheusa )


Rocheusa's picture

About Rocheusa

Roche AG is a Swiss multinational health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange.

Rocheusa press release, blog etc

08/19/2018 - 22:51 China National Drug Administration grants rapid approval of Roches Alecensa (alectinib) as a treatment for ALK-positive lung cancer
08/02/2018 - 19:15 PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntingtons disease
07/31/2018 - 02:44 Roche Purchases Shares in Tender Offer for FMI
07/26/2018 - 12:58 Roche reports very strong performance in the first half of 2018
07/23/2018 - 10:10 Roche receives CE Mark for its Accu-Chek Solo micropump system
07/19/2018 - 21:22 Roche to present new data demonstrating the breadth and depth of its Alzheimers programme at the upcoming Alzheimer's Association International Conference
07/19/2018 - 20:11 FDA grants Breakthrough Device Designation for Roche's Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer's disease
07/19/2018 - 19:04 Roches Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in the initial treatment of people with advanced lung cancer
07/18/2018 - 19:01 FDA grants Breakthrough Therapy Designation for Roches Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC)
07/17/2018 - 05:47 Phase III CAPSTONE-2 study showed that baloxavir marboxil reduced symptoms in people at high risk of complications from the flu
07/02/2018 - 10:42 Phase III IMpassion130 study showed Roches Tecentriq plus Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer
07/02/2018 - 09:19 Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash
06/24/2018 - 21:21 Roches TECENTRIQ in combination with chemotherapy helped people with previously-untreated extensive-stage small cell lung cancer live significantly longer compared to chemotherapy
06/19/2018 - 16:25 Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology
06/15/2018 - 11:00 New long-term data confirm Roches Gazyva/Gazyvaro extends the lives of people with chronic lymphocytic leukaemia compared to MabThera/Rituxan
06/14/2018 - 11:08 Roche announces new OCREVUS (ocrelizumab) data on long-term disability benefits in primary progressive multiple sclerosis and initiation of two global studies in progressive multiple sclerosis
06/13/2018 - 10:14 FDA approves Roches Avastin (bevacizumab) plus chemotherapy as a treatment for women with advanced ovarian cancer following initial surgery
06/10/2018 - 23:41 Roche announces FDA approval for Venclexta plus Rituxan for people with previously treated chronic lymphocytic leukaemia